Beyond the GIST: Mesenchymal tumors of the stomach

Radiographics

Volumn 33, Issue 6, 2013, Pages 1673-1690

  Kang, Hyunseon C ^a   Menias, Christine O ^b   Gaballah, Ayman H ^c   Shroff, Stuti ^a   Taggart, Melissa W ^a   Garg, Naveen ^a   Elsayes, Khaled M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ARTICLE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; MESODERM; PATHOLOGY; STOMACH; STOMACH TUMOR;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MESODERM; STOMACH; STOMACH NEOPLASMS;

EID: 84885338178     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.336135507     Document Type: Article

References (53)

1. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors: pathology and genetics of tumours of the digestive system. Lyon, France: IARC, 2000.
2. Lee NK, Kim S, Kim GH, et al. Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. RadioGraphics 2010;30(7):1915-1934.
3. Horton KM, Fishman EK. Current role of CT in imaging of the stomach. RadioGraphics 2003;23(1): 75-87.
4. Ba-Ssalamah A, Prokop M, Uffmann M, Pokieser P, Teleky B, Lechner G. Dedicated multidetector CT of the stomach: spectrum of diseases. RadioGraphics 2003;23(3):625-644.
5. Johnson PT, Horton KM, Fishman EK. Hypervascular gastric masses: CT findings and clinical correlates. AJR Am J Roentgenol 2010;195(6): W415-W420.
6. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15(4):1293-1301.
7. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11(8):728-734.
8. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344(14):1052-1056.
9. Benjamin RS, Choi H, Macapinlac HA, et al. We should desist using RECIST, at least in GIST. J Clin Oncol 2007;25(13):1760-1764.
10. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299(5607):708-710.
11. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438(1):1-12.
12. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. RadioGraphics 2003;23(2):283-304.
13. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995;103(1):41-47.
14. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33(5):459-465.
15. Agaimy A. Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. Int J Clin Exp Pathol 2010;3(5):461-471.
16. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226(2):527-532.
17. Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996;13(4):297-313.
18. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231 (1):51-58.
19. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32(2):210-218.
20. Agaimy A, Wünsch PH. True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute. Langenbecks Arch Surg 2007;392(1):75-81.
21. Turner MS, Goldsmith JD. Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract. Arch Pathol Lab Med 2009;133(9):1370-1374.
22. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000;24(10):1339-1352.
23. Aggarwal G, Sharma S, Zheng M, et al. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era. Ann Diagn Pathol 2012;16(6):532-540.
24. Thompson WM, Kende AI, Levy AD. Imaging characteristics of gastric lipomas in 16 adult and pediatric patients. AJR Am J Roentgenol 2003;181(4): 981-985.
25. Hur BY, Kim SH, Choi JY, et al. Gastroduodenal glomus tumors: differentiation from other subepithelial lesions based on dynamic contrast-enhanced CT findings. AJR Am J Roentgenol 2011;197(6): 1351-1359.
26. Lee MJ, Lim JS, Kwon JE, et al. Gastric true leiomyoma: computed tomographic findings and pathological correlation. J Comput Assist Tomogr 2007; 31(2):204-208.
27. Sarlomo-Rikala M, Miettinen M. Gastric schwannoma: a clinicopathological analysis of six cases. Histopathology 1995;27(4):355-360.
28. Levy AD, Quiles AM, Miettinen M, Sobin LH. Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol 2005;184(3):797-802.
29. Hong HS, Ha HK, Won HJ, et al. Gastric schwannomas: radiological features with endoscopic and pathological correlation. Clin Radiol 2008;63(5): 536-542.
30. Voltaggio L, Murray R, Lasota J, Miettinen M. Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature. Hum Pathol 2012;43(5):650-659.
31. Agaimy A, Märkl B, Kitz J, et al. Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants. Virchows Arch 2010;456(4):411-422.
32. Williamson JM, Wadley MS, Shepherd NA, Dwerryhouse S. Gastric schwannoma: a benign tumour often mistaken clinically, radiologically and histopathologically for a gastrointestinal stromal tumour-a case series. Ann R Coll Surg Engl 2012;94(4): 245-249.
33. de Rezende NA, Arantes V, de Toledo LL, et al. Plexiform neurofibroma: an unusual cause of GI bleeding and intestinal obstruction. Gastrointest Endosc 2009;70(2):396-398.
34. Bakker JR, Haber MM, Garcia FU. Gastrointestinal neurofibromatosis: an unusual cause of gastric outlet obstruction. Am Surg 2005;71(2):100-105.
35. Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 2002;26(3):301-311.
36. Levy AD, Abbott RM, Rohrmann CA Jr, Frazier AA, Kende A. Gastrointestinal hemangiomas: imaging findings with pathologic correlation in pediatric and adult patients. AJR Am J Roentgenol 2001;177 (5):1073-1081.
37. Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg 1998; 33(7):1163-1167.
38. Vanek J. Gastric submucosal granuloma with eosinophilic infiltration. Am J Pathol 1949;25(3): 397-411.
39. Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol 2009;6(6):331-341.
40. Harned RK, Buck JL, Shekitka KM. Inflammatory fibroid polyps of the gastrointestinal tract: radiologic evaluation. Radiology 1992;182(3):863-866.
41. Daum O, Hes O, Vanecek T, et al. Vanek's tumor (inflammatory fibroid polyp): report of 18 cases and comparison with three cases of original Vanek's series. Ann Diagn Pathol 2003;7(6):337-347.
42. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31(4):509-520.
43. Karnak I, Senocak ME, Ciftci AO, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg 2001;36(6):908-912.
44. Oto A, Akata D, Besim A. Peritoneal inflammatory myofibroblastic pseudotumor metastatic to the liver: CT findings. Eur Radiol 2000;10(9):1501.
45. Miettinen M, Makhlouf HR, Sobin LH, Lasota J. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol 2009;33(11):1624-1632.
46. Takahashi Y, Suzuki M, Fukusato T. Plexiform angiomyxoid myofibroblastic tumor of the stomach. World J Gastroenterol 2010;16(23):2835-2840.
47. Levy AD, Sobin LH. Gastrointestinal carcinoids: imaging features with clinicopathologic comparison. RadioGraphics 2007;27(1):237-257.
48. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97(4): 934-959.
49. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104(4): 994-1006.
50. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996;20(2):168-172.
51. Cadiot G, Cattan D, Mignon M. Diagnosis and treatment of ECL cell tumors. Yale J Biol Med 1998; 71(3-4):311-323.
52. Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG. Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol 2001;176(4):947-951.
53. Dakin GF, Warner RR, Pomp A, Salky B, Inabnet WB. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol 2006;93(5): 368-372.